• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCOVID-19 vaccines

COVID-19 vaccines

Page 89 of 95
A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against COVID-19 at the Baragwanath Hospital on June 28, 2020 in Soweto, South Africa.
Health
How to stop vaccine nationalism from prolonging the pandemic
By David MeyerFebruary 7, 2021
Why haven’t China’s COVID vaccine makers published more data?
Health
Why haven’t China’s COVID vaccine makers published more data?
By Grady McGregorFebruary 5, 2021
SERBIA-HEALTH-VIRUS-VACCINE
Health
Why I took China’s Sinopharm vaccine, despite its lack of data
By Grady McGregorFebruary 5, 2021
In this photo illustration a medical syringe seen displayed
Health
Johnson & Johnson asks FDA for emergency authorization of its single-dose COVID vaccine
By Riley Griffin and BloombergFebruary 4, 2021
Map: 4 states have reached more than 10% of their populations with the vaccine
Health
Map: 4 states have reached more than 10% of their populations with the vaccine
By Erika Fry and Nicolas RappFebruary 3, 2021
What happened at Fortune’s not-in-Davos gathering of business leaders
Leadership
What happened at Fortune’s not-in-Davos gathering of business leaders
By Fortune EditorsFebruary 3, 2021
A man getting an injection.
Health
The AstraZeneca vaccine cuts COVID transmission—and delaying the second dose is a good idea, study finds
By Jeremy KahnFebruary 3, 2021
CNV.0321.Albert Bourla-featured
Magazine
Pfizer’s CEO thinks a vaccine-resistant COVID variant is ‘likely’—but that’s not as scary as it sounds
By Clifton LeafFebruary 3, 2021
Russia’s Sputnik V vaccine shows 91.6% efficacy rate, peer-reviewed findings say
Health
Russia’s Sputnik V vaccine shows 91.6% efficacy rate, peer-reviewed findings say
By Yuliya Fedorinova, Stepan Kravchenko and BloombergFebruary 2, 2021
Johnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
Health
Johnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
By Kat EschnerFebruary 1, 2021
01 February 2021, Lower Saxony, Lingen: Senior citizen Maria Hesemann-Peters is vaccinated against the corona virus with the active ingredient from Biontech/Pfizer by emergency paramedic Bernd Rode from the DRK (German Red Cross) at the vaccination centre in the Emslandhallen.
Health
Why Europe’s summer COVID vaccination target could still be on track
By David MeyerFebruary 1, 2021
How vaccine nationalism could extend the pandemic
Health
How vaccine nationalism could extend the pandemic
By James Paton and BloombergJanuary 31, 2021
President Biden Delivers Remarks On His Racial Equity Agenda And Signs Executive Actions
Politics
Joe Biden’s cabinet: What you need to know about the President’s key advisers and their top priorities
By Nicole GoodkindJanuary 31, 2021
Tom Richmond receives his AstraZeneca/Oxford University Covid-19 vaccine from Vaccinator Louise Chadwick at Acklam Road pharmacy on January 28, 2021 in Middlesbrough, England.
Health
With supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults
By Jeremy Kahn and David MeyerJanuary 29, 2021
The 3 major fixes broken health systems need, according to experts
Health
The 3 major fixes broken health systems need, according to experts
By Erika FryJanuary 29, 2021
1...
  • 87
  • 88
  • 89
  • 90
  • 91
...95
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.